Diplomat Pharmacy to Distribute Recently Approved PARP Inhibitor Zejula in the US
News
Diplomat Pharmacy will be one of the companies distributing Zejula (niraparib), a recently approved treatment for women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in the United ... Read more